|
关注：1
2013-05-23 12:21
求翻译：Overview Dainippon Sumitomo (formerly Sumitomo) is developing the platinum complex, miriplatin (MIRIPLA;SM 11355), for the potential treatment of hepatocellular carcinoma. In January 2010, miriplatin was launched in Japan for this indication as intra-arterial injection and suspension vehicle formulations. In 1985 a pri是什么意思？ 待解决
 悬赏分：1
- 离问题结束还有
Overview Dainippon Sumitomo (formerly Sumitomo) is developing the platinum complex, miriplatin (MIRIPLA;SM 11355), for the potential treatment of hepatocellular carcinoma. In January 2010, miriplatin was launched in Japan for this indication as intra-arterial injection and suspension vehicle formulations. In 1985 a pri
问题补充： |
|
2013-05-23 12:21:38
概述大日本住友（原住友）正在开发的铂配合物的，miriplatin（11355 MIRIPLA; SM），为对肝癌的潜在治疗。 miriplatin是在2010年1月，在日本推出这表明动脉内注射和悬挂车辆配方。在1985年优先专利申请在日本
|
|
2013-05-23 12:23:18
(formerly Overview Dainippon Sumitomo Sumitomo) is developing the platinum (MIRIPLA miriplatin complex, 11,355 ; SM), for the treatment of hepatocellular carcinoma potential In January . was launched in 2010, miriplatin Japan for this indication as intra-arterial injection and vehicle suspension for
|
|
2013-05-23 12:24:58
Overview Dainippon Sumitomo (formerly Sumitomo) is developing the platinum complex, miriplatin (MIRIPLA; SM 11355), for the potential treatment of hepatocellular carcinoma. In January 2010, miriplatin was launched in Japan for this indication as intra-arterial injection and suspension vehicle formul
|
|
2013-05-23 12:26:38
Overview Dainippon Sumitomo (formerly Sumitomo) is developing the platinum complex, miriplatin (MIRIPLA; SM 11355), for the potential treatment of hepatocellular carcinoma. In January 2010, miriplatin was launched in Japan for this indication as intra-arterial injection and suspension vehicle formul
|
|
2013-05-23 12:28:18
Overview Dainippon Sumitomo (formerly Sumitomo) is developing the platinum complex, miriplatin (MIRIPLA; SM 11355), for the potential treatment of hepatocellular carcinoma. In January 2010, miriplatin was launched in Japan for this indication as intra-arterial injection and suspension vehic le formu
|
湖北省互联网违法和不良信息举报平台 | 网上有害信息举报专区 | 电信诈骗举报专区 | 涉历史虚无主义有害信息举报专区 | 涉企侵权举报专区
